Furthermore, exposure to each inhibitor (LY294002, AKI, or U0126, at lower dose indicated above) increased the ratio of phospho-EGFR to EGFR upon ligand stimulation (Additional file 1: Figure S2C), consistent with the role of SHKBP1 in regulating EGFR activity. The gene discussed is SHKBP1; the disease is acute kidney injury.